http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2021000819-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f04a7ce8ccfdef9295e801182d0879d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c20a5fdfd3754705fe63881d9e0084c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0a6c88e00ce94f1bf85753d178c95f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69222eaf7955727700b38020caef3bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21db6451ff2280f6314cf9942063434d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e0e1a54124f2f276d9e8880110c0328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661e8c882034c8dccfb71ff4bbe08018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ece63ae8bd496c0d3aba6db83812d40
publicationDate 2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2021000819-A1
titleOfInvention Sustained administration of angiopoietin-like polypeptides 3
abstract Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related to the same, pharmaceutical compositions comprising drug delivery systems and the use of drug delivery systems as sustained release therapeutics
priorityDate 2018-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288

Total number of triples: 33.